These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23721135)

  • 21. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
    Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
    Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
    Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
    Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
    Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
    Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasis.
    Suenaga Y; Kitajima K; Aoki H; Okunaga T; Kono A; Matsumoto I; Fukumoto T; Tanaka K; Sugimura K
    Eur J Radiol; 2013 Oct; 82(10):1696-701. PubMed ID: 23768610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.
    Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P
    Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
    Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
    Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of whole-body MRI to detect the recurrence of lung cancer.
    Lee MH; Kim SR; Park SY; Park SJ; Lee EJ; Jin GY; Lee YC
    Magn Reson Imaging; 2012 Dec; 30(10):1439-45. PubMed ID: 22817957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
    Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
    Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
    Li S; Sun F; Jin ZY; Xue HD; Li ML
    J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.
    Cafagna D; Rubini G; Iuele F; Maggialetti N; Notaristefano A; Pinto D; Niccoli-Asabella A; Palmiotti G; Lasciarrea M; Maggialetti A
    Radiol Med; 2012 Mar; 117(2):293-311. PubMed ID: 21744252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
    Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
    Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.
    Stecco A; Romano G; Negru M; Volpe D; Saponaro A; Costantino S; Sacchetti G; Inglese E; Alabiso O; Carriero A
    Radiol Med; 2009 Feb; 114(1):1-17. PubMed ID: 19082787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
    Pfannenberg C; Schwenzer N
    Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
    Albano D; Patti C; La Grutta L; Agnello F; Grassedonio E; Mulè A; Cannizzaro G; Ficola U; Lagalla R; Midiri M; Galia M
    Eur J Radiol; 2016 Feb; 85(2):313-8. PubMed ID: 26781135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of four MRI protocols for detection of extrahepatic colorectal cancer metastases.
    Sivesgaard K; Jöhnk ML; Larsen LP; Sørensen M; Kramer S; Løgager VB; Hansen F; Pedersen EM
    J Magn Reson Imaging; 2017 Dec; 46(6):1619-1630. PubMed ID: 28301099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy.
    Paruthikunnan SM; Kadavigere R; Karegowda LH
    AJR Am J Roentgenol; 2017 Sep; 209(3):477-490. PubMed ID: 28678578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T.
    Mürtz P; Kaschner M; Träber F; Kukuk GM; Büdenbender SM; Skowasch D; Gieseke J; Schild HH; Willinek WA
    Eur J Radiol; 2012 Nov; 81(11):3614-23. PubMed ID: 22178311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.